Abstract

Phosphonoformic acid (PFA) and its congener phosphonoacetic acid (PAA) are inhibitors of viral (and to a less extent mammalian) DNA polymerase. We selected mutants of S49 cells (a mouse T lymphoma line) resistant to 3mM phosphonoformic acid. These 11 lines had a range of growth rates, cell cycle distribution abnormalities, and concomitant resistance to the inhibitory effects of thymidine, acycloguanosine (acyclovir), aphidicolin, deoxyadenosine, and novobiocin. Most lines had normal to slightly elevated pools of ribonucleoside triphosphates and deoxyribonucleoside triphosphates. However, one line (PFA 3-9) had a greatly elevated dCTP pool and increased CDP reducatase activity in permeabilized cells. This activity in the PFA 3-9 cells diminished to wild type control levels in the presence of phosphonoformic acid, while PFA greatly diminished wild type CDP reductase activity (see table). In addition, 4mM PFA diminished the dCTP pool in wild type and in PFA 3-9 cells at 8 hours. The reduced dCTP pool could be increased by exogenous deoxycytidine but this only marginally reversed PFA toxicity. These observations suggest that PFA is an inhibitor of mammalian ribonucleotide reductase and partial resistance to PFA can be effected by mutation to increased CDP reductase activity resulting in a large dCTP pool.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.